Stroke Recurrence, Transient Ischemic Attack
Conditions
Keywords
Stroke, Ischemic Stroke, Transient Ischemic Attack, Stroke Recurrence Prevention, Cerebrovascular Disorders, Brain Ischemia, Brain Infraction, Brain Diseases, Cerebral Infraction, Self-management, Peer-led, Community Based
Brief summary
The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.
Detailed description
Twenty nine percent of the 700,000 strokes that occur yearly nationwide are among stroke survivors. Blacks, both nationally and among Harlem residents, have a twofold increase in recurrent strokes. Harlem Latinos have a threefold increase in risk relative to Whites. Primary risk factors for recurrent stroke include hypertension, hyperlipidemia, and under use of anti-thrombotic agents. Controlling risk factors can be particularly challenging for low-income, minority populations who lack the resources needed to adhere to necessary therapies. In Harlem, 72% of adults studied six months post stroke did not have these three risk factors treated adequately. We propose to determine if participation in a recurrent stroke prevention educational intervention, versus usual care, can activated stroke survivors to at reduce primary risk factors for recurrent strokes while providing an effective, low-cost, sustainable recurrent stroke prevention program in neighborhoods like Harlem, whose residents bear a disproportionate burden of suffering from strokes. Specifically, we propose: 1. Recruit 600 adults who sustained a stroke or transient ischemic attack (TIA) within the past five years by working with Harlem community leaders, local clinical sites including the Mount Sinai Medical Center and the Institute for Family Health, and the Visiting Nurse Service of New York; 2. To conduct a randomized, controlled trial to determine if participation in a peer-led stroke prevention program activates stroke and TIA survivors to improve their knowledge and self-management strategies and treatments related to stroke prevention; and 3. To rigorously compare the impact of the intervention with usual care (delayed intervention), on increasing the proportion of individuals with strokes and TIAs who are appropriately treated to reduce the risk of recurrent events, specifically through control of hypertension (blood pressure ≤ 140/90mmHg), hyperlipidemia (LDL cholesterol≤100 mg/dl) and use of anti-thrombotic medicines.
Interventions
Prevent Return of Stroke is a community-based, peer-led stroke recurrence prevention program. This is a bilingual (English/Spanish) education program written at a 4th grade reading level, and contains simple, actionable, messages, easily taught by lay leaders, and focuses on enhancing self-efficacy to make lifestyle changes, to help reduce stroke recurrence risk factors. It consists of 6 sessions (1½ hours each) held over 6-weeks. Topics include learning the risk factors for stroke, controlling hypertension, LDL cholesterol, preventing blood clots, medication adherence, and stress management.The intervention arm will participate in the intervention shortly after enrolling in the trial.
Sponsors
Study design
Eligibility
Inclusion criteria
* Had a stroke or TIA diagnosed within 5 years * 40 years of age or older * Able to participate in group education classes * English or Spanish speaking * Community dwelling
Exclusion criteria
* No incidence of stroke or TIA * Stroke or TIA occurred more than 5 years ago * less than 40 years of age * Cognitive or physical impairment that would preclude comprehension of a conversation and communicating as part of a group (i.e., dementia, deafness, inability to speak, aphasia) * Self-reported terminal illness with life expectancy of less than 1 year * Plans to relocate from New York City within one year of enrollment * Pregnant * Nursing home resident * Prisoner
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood Pressure | 6 months post enrollment into trial | Percentage of Participants with Blood Pressure controlled at \<140/90 mm Hg |
| LDL Cholesterol | 6 months post enrollment into trial | Percentage of participants with controlled Low Density Lipoprotein low (LDL) of less than 100 mg/dL |
| Use of Anti-thrombotic Medication | 6 months post enrollment into trial | Number of participants taking anti-thrombotic medication |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Knowledge and Attitudes About Stroke Recurrence Risk | 6 months post enrollment into trial | — |
| Access to Medical Care | 6 months post enrollment into trial | Number of participants who have a primary care doctor |
| Medication Adherence | 6 months post enrollment into trial | Number of participants adherent to medications as determined with Morisky score ≥ 6 Adherence to medications was measured using the 8-item Morisky Medication Adherence Questionnaire (Morisky). The questionnaire has been validated against an objective measure of adherence and has been used in racially diverse and elderly patient samples. Scores on the questionnaire can be used to classify patients into low and high adherence groups. Consistent with standard cut points, participants who scored less than 6 points on the Morisky were categorized as nonadherent to medications and participants who scored 6 to 8 points were categorized as adherent. |
| Emotional Health | 6 months post enrollment into trial | Number of participants diagnosed as depressed utilizing depression scale. Participant is determined to be depressed if Patient Health Questionnaire (PHQ8) ≥ 10. Scale has a total score between 0 and 24 points. A total score of 0 to 4 represents no significant depressive symptoms. A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe. |
Countries
United States
Participant flow
Recruitment details
Participants were enrolled from June 2009 to June 2012 recruited at community based sites as well as clinical sites.
Participants by arm
| Arm | Count |
|---|---|
| Peer-Led Stroke Recurrence Prevention Education The intervention group participated in a 6-session course held over a 6-week period. The Prevent Return of Stroke Workshop, led by trained peer educators, aimed to help participants control the risk factors for stroke, thereby preventing recurrence of strokes.
Prevent Return of Stroke: Prevent Return of Stroke is a community-based, peer-led stroke recurrence prevention program. This is a bilingual (English/Spanish) education program written at a 4th grade reading level, and contains simple, actionable, messages, easily taught by lay leaders, and focuses on enhancing self-efficacy to make lifestyle changes, to help reduce stroke recurrence risk factors. It consists of 6 sessions (1½ hours each) held over 6-weeks. Topics include learning the risk factors for stroke, controlling hypertension, LDL cholesterol, preventing blood clots, medication adherence, and stress management.The intervention arm will participate in the intervention shortly after enrolling in the trial. | 301 |
| Usual Care (Delayed Intervention) The control group was offered the chance to take part in the 6-week session intervention after 12 months after enrollment into the trial.
Prevent Return of Stroke: The intervention arm participated in the intervention shortly after enrolling in the trial. The usual care arm was offered the intervention after 12 months from enrolling in the trial. | 299 |
| Total | 600 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Death | 2 | 2 |
| Overall Study | Lost to Follow-up | 57 | 31 |
Baseline characteristics
| Characteristic | Peer-Led Stroke Recurrence Prevention Education | Usual Care (Delayed Intervention) | Total |
|---|---|---|---|
| Age, Continuous | 63 years STANDARD_DEVIATION 11 | 64 years STANDARD_DEVIATION 11 | 63 years STANDARD_DEVIATION 11 |
| Sex: Female, Male Female | 180 Participants | 177 Participants | 357 Participants |
| Sex: Female, Male Male | 121 Participants | 122 Participants | 243 Participants |
| Years since stroke | 1.8 years STANDARD_DEVIATION 1.4 | 1.8 years STANDARD_DEVIATION 1.5 | 1.8 years STANDARD_DEVIATION 1.5 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 301 | 0 / 299 |
| serious Total, serious adverse events | 0 / 301 | 0 / 299 |
Outcome results
Blood Pressure
Percentage of Participants with Blood Pressure controlled at \<140/90 mm Hg
Time frame: 6 months post enrollment into trial
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Peer-Led Stroke Recurrence Prevention Education | Blood Pressure | 76 percentage of participants |
| Usual Care (Delayed Intervention) | Blood Pressure | 65 percentage of participants |
LDL Cholesterol
Percentage of participants with controlled Low Density Lipoprotein low (LDL) of less than 100 mg/dL
Time frame: 6 months post enrollment into trial
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Peer-Led Stroke Recurrence Prevention Education | LDL Cholesterol | 59 percentage of participants |
| Usual Care (Delayed Intervention) | LDL Cholesterol | 57 percentage of participants |
Use of Anti-thrombotic Medication
Number of participants taking anti-thrombotic medication
Time frame: 6 months post enrollment into trial
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Peer-Led Stroke Recurrence Prevention Education | Use of Anti-thrombotic Medication | 199 participants |
| Usual Care (Delayed Intervention) | Use of Anti-thrombotic Medication | 226 participants |
Access to Medical Care
Number of participants who have a primary care doctor
Time frame: 6 months post enrollment into trial
Population: 1 missing response from Usual Care group
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Peer-Led Stroke Recurrence Prevention Education | Access to Medical Care | 232 participants |
| Usual Care (Delayed Intervention) | Access to Medical Care | 240 participants |
Emotional Health
Number of participants diagnosed as depressed utilizing depression scale. Participant is determined to be depressed if Patient Health Questionnaire (PHQ8) ≥ 10. Scale has a total score between 0 and 24 points. A total score of 0 to 4 represents no significant depressive symptoms. A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe.
Time frame: 6 months post enrollment into trial
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Peer-Led Stroke Recurrence Prevention Education | Emotional Health | 46 participants |
| Usual Care (Delayed Intervention) | Emotional Health | 59 participants |
Knowledge and Attitudes About Stroke Recurrence Risk
Time frame: 6 months post enrollment into trial
Medication Adherence
Number of participants adherent to medications as determined with Morisky score ≥ 6 Adherence to medications was measured using the 8-item Morisky Medication Adherence Questionnaire (Morisky). The questionnaire has been validated against an objective measure of adherence and has been used in racially diverse and elderly patient samples. Scores on the questionnaire can be used to classify patients into low and high adherence groups. Consistent with standard cut points, participants who scored less than 6 points on the Morisky were categorized as nonadherent to medications and participants who scored 6 to 8 points were categorized as adherent.
Time frame: 6 months post enrollment into trial
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Peer-Led Stroke Recurrence Prevention Education | Medication Adherence | 159 participants |
| Usual Care (Delayed Intervention) | Medication Adherence | 169 participants |